Allergan PLC | Balance Sheet
Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
332
251
1,105
13,226
6,449
1,907
Total Accounts Receivable
1,405
2,372
2,139
2,625
2,979
2,936
Inventories
1,786
2,076
758
718
905
847
Other Current Assets
912
2,183
4,577
1,289
1,044
785
Total Current Assets
4,435
6,882
8,579
17,858
11,377
6,475
Net Property, Plant & Equipment
1,617
1,595
1,531
1,611
1,785
1,787
Total Investments and Advances
13
65
112
95
72
46
Long-Term Note Receivable
58
58
40
36
32
1,675
Intangible Assets
16,432
43,710
114,301
108,975
104,511
89,609
Other Assets
67
113
10,970
178
245
1,132
Total Assets
22,726
52,529
135,583
128,986
118,342
101,788
ST Debt & Current Portion LT Debt
535
697
2,397
2,798
4,232
Accounts Payable
493
645
216
225
325
Income Tax Payable
132
98
54
58
75
Other Current Liabilities
2,135
3,579
5,626
4,794
5,217
Total Current Liabilities
3,295
5,019
8,292
7,875
9,848
Long-Term Debt
8,517
14,846
40,134
29,971
25,844
Provision for Risks & Charges
236
1,193
1,875
1,799
2,239
Deferred Taxes
718
2,955
7,919
12,736
6,033
Other Liabilities
318
74
724
172
222
Total Liabilities
13,189
24,194
58,994
52,786
44,505
Common Equity (Total)
9,532
28,331
71,662
71,263
68,891
Total Shareholders' Equity
9,532
28,331
76,591
76,193
73,821
Total Equity
9,537
28,336
76,589
76,201
73,837
Liabilities & Shareholders' Equity
22,726
52,529
135,583
128,986
118,342
Accumulated Minority Interest
5
4
2
8
16
Preferred Stock (Carrying Value)
-
-
4,930
4,930
4,930
About Allergan
View Profile
